Skip to content
10-Q

Quarterly Report

ProKidney Corp. PROK

0000950170-25-107352

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Capex Q2 2025 · Jun 30, 2025 $4.25M
Capex Q2 2025 · Jun 30, 2024 $1.6M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$61.01M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$72.94M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $84.94M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $99.12M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$1B
Stockholders Equity Q2 2025 · Mar 31, 2025 −$998.55M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$994.95M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$972.37M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$1.1B
Stockholders Equity Q2 2025 · Dec 31, 2023 −$1.1B
Current Liabilities Q2 2025 · Jun 30, 2025 $28.26M
Current Liabilities Q2 2025 · Dec 31, 2024 $36.22M
Total Liabilities Q2 2025 · Jun 30, 2025 $32.68M
Total Liabilities Q2 2025 · Dec 31, 2024 $39.44M
Current Assets Q2 2025 · Jun 30, 2025 $324.44M
Current Assets Q2 2025 · Dec 31, 2024 $395.88M
Total Assets Q2 2025 · Jun 30, 2025 $372.13M
Total Assets Q2 2025 · Dec 31, 2024 $441.07M
Sga Expense Q2 2025 · Jun 30, 2025 $14.05M
Sga Expense Q2 2025 · Jun 30, 2025 $28.4M
Sga Expense Q2 2025 · Jun 30, 2024 $13.65M
Sga Expense Q2 2025 · Jun 30, 2024 $26.5M
Rd Expense Q2 2025 · Jun 30, 2025 $25.88M
Rd Expense Q2 2025 · Jun 30, 2025 $53.15M
Rd Expense Q2 2025 · Jun 30, 2024 $29.4M
Rd Expense Q2 2025 · Jun 30, 2024 $56.64M
Net Income Q2 2025 · Jun 30, 2025 −$16.55M
Net Income Q2 2025 · Jun 30, 2025 −$33.29M
Net Income Q2 2025 · Jun 30, 2024 −$12.51M
Net Income Q2 2025 · Jun 30, 2024 −$22M
Operating Income Q2 2025 · Jun 30, 2025 −$39.71M
Operating Income Q2 2025 · Jun 30, 2025 −$81.1M
Operating Income Q2 2025 · Jun 30, 2024 −$43.06M
Operating Income Q2 2025 · Jun 30, 2024 −$83.13M
Revenue Q2 2025 · Jun 30, 2025 $221K
Revenue Q2 2025 · Jun 30, 2025 $451K
Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2024 $0